Status:
RECRUITING
Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
Lead Sponsor:
University of California, San Francisco
Conditions:
Hidradenitis Suppurativa
Eligibility:
All Genders
10+ years
Brief Summary
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments ex...
Eligibility Criteria
Inclusion
- Male or female ≥ 10 years of age
- Diagnosis of HS by a dermatologist or practitioner experienced in making a diagnosis of HS
- Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study.
Exclusion
- 1\. Inability to give informed consent or unavailability of a parent/guardian who is able and willing to give informed consent.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04115566
Start Date
August 1 2020
End Date
January 1 2030
Last Update
October 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco
San Francisco, California, United States, 94115